Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Ganciclovir Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Ganciclovir Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Injection
      • 1.3.3 Oral
    • 1.4 Market Segment by Application
      • 1.4.1 Global Ganciclovir Market Share by Application (2019-2025)
      • 1.4.2 AIDS
      • 1.4.3 Tube transplant
      • 1.4.4 Malignant neoplasms
      • 1.4.5 CMV Infection
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Ganciclovir Market Size
      • 2.1.1 Global Ganciclovir Revenue 2014-2025
      • 2.1.2 Global Ganciclovir Sales 2014-2025
    • 2.2 Ganciclovir Growth Rate by Regions
      • 2.2.1 Global Ganciclovir Sales by Regions 2014-2019
      • 2.2.2 Global Ganciclovir Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Ganciclovir Sales by Manufacturers
      • 3.1.1 Ganciclovir Sales by Manufacturers 2014-2019
      • 3.1.2 Ganciclovir Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Ganciclovir Revenue by Manufacturers (2014-2019)
      • 3.2.2 Ganciclovir Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Ganciclovir Market Concentration Ratio (CR5 and HHI)
    • 3.3 Ganciclovir Price by Manufacturers
    • 3.4 Key Manufacturers Ganciclovir Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Ganciclovir Market
    • 3.6 Key Manufacturers Ganciclovir Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Injection Sales and Revenue (2014-2019)
      • 4.1.2 Oral Sales and Revenue (2014-2019)
    • 4.2 Global Ganciclovir Sales Market Share by Type
    • 4.3 Global Ganciclovir Revenue Market Share by Type
    • 4.4 Ganciclovir Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Ganciclovir Sales by Application

    6 United States

    • 6.1 United States Ganciclovir Breakdown Data by Company
    • 6.2 United States Ganciclovir Breakdown Data by Type
    • 6.3 United States Ganciclovir Breakdown Data by Application

    7 European Union

    • 7.1 European Union Ganciclovir Breakdown Data by Company
    • 7.2 European Union Ganciclovir Breakdown Data by Type
    • 7.3 European Union Ganciclovir Breakdown Data by Application

    8 China

    • 8.1 China Ganciclovir Breakdown Data by Company
    • 8.2 China Ganciclovir Breakdown Data by Type
    • 8.3 China Ganciclovir Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Ganciclovir Breakdown Data by Company
    • 9.2 Rest of World Ganciclovir Breakdown Data by Type
    • 9.3 Rest of World Ganciclovir Breakdown Data by Application
    • 9.4 Rest of World Ganciclovir Breakdown Data by Countries
      • 9.4.1 Rest of World Ganciclovir Sales by Countries
      • 9.4.2 Rest of World Ganciclovir Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Roche
      • 10.1.1 Roche Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.1.4 Ganciclovir Product Introduction
      • 10.1.5 Roche Recent Development
    • 10.2 Bausch & Lomb
      • 10.2.1 Bausch & Lomb Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.2.4 Ganciclovir Product Introduction
      • 10.2.5 Bausch & Lomb Recent Development
    • 10.3 Fresenius Kabi
      • 10.3.1 Fresenius Kabi Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.3.4 Ganciclovir Product Introduction
      • 10.3.5 Fresenius Kabi Recent Development
    • 10.4 Luitpold
      • 10.4.1 Luitpold Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.4.4 Ganciclovir Product Introduction
      • 10.4.5 Luitpold Recent Development
    • 10.5 Huatai Pharmaceutical
      • 10.5.1 Huatai Pharmaceutical Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.5.4 Ganciclovir Product Introduction
      • 10.5.5 Huatai Pharmaceutical Recent Development
    • 10.6 Wuhan Hualong Bio-pharmaceutical
      • 10.6.1 Wuhan Hualong Bio-pharmaceutical Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.6.4 Ganciclovir Product Introduction
      • 10.6.5 Wuhan Hualong Bio-pharmaceutical Recent Development
    • 10.7 Luoxin
      • 10.7.1 Luoxin Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.7.4 Ganciclovir Product Introduction
      • 10.7.5 Luoxin Recent Development
    • 10.8 HUBEI KEYI
      • 10.8.1 HUBEI KEYI Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.8.4 Ganciclovir Product Introduction
      • 10.8.5 HUBEI KEYI Recent Development
    • 10.9 Tungshun Group
      • 10.9.1 Tungshun Group Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.9.4 Ganciclovir Product Introduction
      • 10.9.5 Tungshun Group Recent Development
    • 10.10 Tiantianming
      • 10.10.1 Tiantianming Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Ganciclovir
      • 10.10.4 Ganciclovir Product Introduction
      • 10.10.5 Tiantianming Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Ganciclovir Sales Channels
      • 11.2.2 Ganciclovir Distributors
    • 11.3 Ganciclovir Customers

    12 Market Forecast

    • 12.1 Global Ganciclovir Sales and Revenue Forecast 2019-2025
    • 12.2 Global Ganciclovir Sales Forecast by Type
    • 12.3 Global Ganciclovir Sales Forecast by Application
    • 12.4 Ganciclovir Forecast by Regions
      • 12.4.1 Global Ganciclovir Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Ganciclovir Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Ganciclovir is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ganciclovir.

      This report studies the global market size of Ganciclovir, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Ganciclovir sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Roche
      Bausch & Lomb
      Fresenius Kabi
      Luitpold
      Huatai Pharmaceutical
      Wuhan Hualong Bio-pharmaceutical
      Luoxin
      HUBEI KEYI
      Tungshun Group
      Tiantianming

      Market Segment by Product Type
      Injection
      Oral

      Market Segment by Application
      AIDS
      Tube transplant
      Malignant neoplasms
      CMV Infection

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Ganciclovir status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Ganciclovir manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Ganciclovir are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now